YD Bio (YDES)
NasdaqMarket Closed
YD Bio Limited is a biotechnology and healthcare services company with activities spanning regulated diagnostics, life science support services, and healthcare product commercialisation. The company operates across the United States and Taiwan, with Taiwan currently representing its largest revenue-generating market.
A core part of YD Bio’s business is linked to oncology diagnostics. The company is involved in DNA methylation-based cancer testing programmes in the United States under a laboratory developed test, or LDT, framework. These programmes are conducted with laboratory partners that are CLIA-certified and CAP-accredited, reflecting the regulated environment in which clinical laboratory testing is performed. DNA methylation analysis is an area of growing interest in cancer detection and monitoring because it examines epigenetic changes that may be associated with disease biology.
Beyond diagnostics, YD Bio provides life science distribution and clinical trial supply chain services. These activities can include procurement, logistics coordination, and compliance-focused support for organisations running clinical development programmes. Such services are important in biotechnology and pharmaceutical research, where timely delivery, documentation, and regulatory alignment can affect trial execution.
The company also maintains healthcare product commercialisation operations, including ocular health products in the United States and consumer healthcare distribution in Asia. This mix gives YD Bio exposure to both specialised clinical markets and broader healthcare product channels. For investors, the company’s profile is shaped by its ability to advance diagnostic programmes, maintain high-quality laboratory and distribution partnerships, and manage commercial execution across different regulatory and regional markets.
Last updated
- Market Cap
- $162,912,096
- P/E
- —
- P/FCF
- —
- P/S
- —
- Enterprise Value
- —
- Sector
- —
- Industry
- —
- Address
- —
Top Biotech Gainers: LUCY Shines, SEER Gets Takeover Offer, OFIX, ENOV Rally On CMS Update
YD Bio Limited Reports Full Year 2025 Financial Results
YD Bio Outlines An Ambitious 2026 Roadmap Following A Transformative 2025
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring
YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES
YD Bio Business Partner EG Biomed Achieves CAP Accreditation, Advancing U.S. Clinical Testing Capabilities
YD Bio Limited Reports Unaudited Half Year 2025 Financial Results
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- $162,912,096
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- —
- P/E
P/E ratio compares a company's share price to its earnings per share.
- —
- P/B
P/B ratio compares a company's share price to its book value per share.
- —
- P/S
P/S ratio compares a company's share price to its revenue per share.
- —
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- —
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- —
- EPS
- —
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- —
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- —
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- —
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- —
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- —
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- —
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- —
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- —
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- —
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- —
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- —
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- —
Financial statements are not available for this listing.
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 424B3 — YD Bio Ltd | View Filing | |
| edgar index | 4 — YD Bio Ltd | View Filing | |
| edgar index | 4 — YD Bio Ltd | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| edgar index | EFFECT — YD Bio Ltd | View Filing | |
| edgar index | POS AM — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 20-F — YD Bio Ltd | View Filing | |
| edgar index | 3/A — YD Bio Ltd | View Filing | |
| form 3 | Form 3 — Lu Shao-Ta | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| edgar index | 4 — YD Bio Ltd | View Filing | |
| edgar index | 4 — YD Bio Ltd | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Chang Kochi | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| form 4 | Form 4 — Lu Shao-Ta | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| form 3 | Form 3 — Zhang Bo-Xiang | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| edgar index | 3 — YD Bio Ltd | View Filing | |
| form 3 | Form 3 — Shen Ethan PhD | View Filing | |
| form 3 | Form 3 — Shen Ethan PhD | View Filing | |
| edgar index | 424B3 — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | SCHEDULE 13G/A — YD Bio Ltd | View Filing | |
| edgar index | 424B3 — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | S-8 — YD Bio Ltd | View Filing | |
| edgar index | SCHEDULE 13G — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 424B3 — YD Bio Ltd | View Filing | |
| edgar index | F-1/A — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | UPLOAD — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | F-1 — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 20FR12B — YD Bio Ltd | View Filing | |
| edgar index | CERT — YD Bio Ltd | View Filing | |
| edgar index | 8-A12B — YD Bio Ltd | View Filing | |
| edgar index | 6-K — YD Bio Ltd | View Filing | |
| edgar index | 424B3 — YD Bio Ltd | View Filing | |
| edgar index | EFFECT — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing | |
| edgar index | UPLOAD — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing | |
| edgar index | UPLOAD — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing | |
| edgar index | UPLOAD — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing | |
| edgar index | UPLOAD — YD Bio Ltd | View Filing | |
| edgar index | F-4/A — YD Bio Ltd | View Filing | |
| edgar index | CORRESP — YD Bio Ltd | View Filing |